LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

Protagonist Therapeutics Inc

Closed

Sector Healthcare

41.38 -1.41

Overview

Share price change

24h

Current

Min

41.25

Max

41.68

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+10.84 upside

Dividends

By Dow Jones

Next Earnings

30 paź 2024

News Sentiment

By Acuity

50%

50%

114 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Protagonist Therapeutics Inc Chart

Related News

31 sty 2024, 23:58 UTC

Major Market Movers

Protagonist Therapeutics Shares Rise 5.6% on Licensing Deal With Takeda

Peer Comparison

Price change

Protagonist Therapeutics Inc Forecast

Price Target

By TipRanks

10.84% upside

12 Months Forecast

Average 46 USD  10.84%

High 51 USD

Low 40 USD

Based on 5 Wall Street analysts offering 12 month price targets forProtagonist Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

40.8 / 42.065Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Neutral Evidence

Long Term

Weak Bullish Evidence

Sentiment

By Acuity

114 / 365 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Above average